Filter
375
Filtered Results: 375
Text search:
Pfizer
Featured
Recommendations
44
New Publications
120
Language
Document type
No document type
103
Guidelines
82
Studies & Reports
76
Fact sheets
43
Manuals
23
Strategic & Response Plan
18
Resource Platforms
10
Infographics
5
Training Material
4
Situation Updates
4
Videos
4
Online Courses
3
Countries / Regions
Brazil
18
Russia
13
Global
11
Argentina
10
Germany
9
South Africa
9
Ukraine
8
Latin America and the Carribbean
7
Middle East and North Africa
7
Mozambique
6
Chile
5
India
5
Africa
4
West and Central Africa
4
Western and Central Europe
4
Ecuador
4
Colombia
3
China
3
Senegal
3
Paraguay
3
East and Southern Africa
3
Nepal
2
Kenya
2
El Salvador
2
Nigeria
2
Peru
2
Philippines
2
South–East Asia Region
2
Uganda
2
Eastern Europe
2
Indonesia
2
Liberia
2
Timor Leste/ East Timor
1
Ghana
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Syria
1
Iran
1
Congo-Brazzaville
1
Guinea-Bissau
1
Tanzania
1
Congo, Democratic Republic of
1
Eastern Europe and Central Asia
1
United Kingdom
1
Belarus
1
Lebanon
1
Bangladesh
1
Sudan
1
Yemen
1
Angola
1
Chad
1
South Sudan
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
COVID-19
87
Guidelines
33
Studies & Reports
28
Reproductive Health
10
Policies
9
Drugs & Medical Equipment
8
Information, Education and Communication (IEC)
8
Vaccine-preventable Diseases
7
Women & Child Health
7
Dental & Eye Care
4
Paediatrics
4
x MEDBOX Issue Brief & Annual Reports x
4
Pediatrics
4
Capacity Building
4
Statistics
4
Diabetes
3
Maternal & Child Health
3
Humanitarian Crisis
3
Schistosomiasis
2
IEC Material
2
Community Health
2
Surgery & Anaesthesia
2
Gynaecology & Obstetrics
2
Health Systems
2
NTDs & Others
2
Maternal Health
2
HIV & STI
2
Age & Elderly
2
TB
2
Hepatitis
1
Helminthiasis
1
Yaws
1
Child Health
1
Buruli Ulcer
1
Onchocerciasis
1
Lymphaticfilariasis
1
Annual Report MEDBOX
1
Community Health
1
MPOX - Monkeypox
1
Infection Control & Prevention (IPC)
1
Medical Devices & Equipment
1
Policies & Guidelines HIV & TB
1
WASH
1
General Guidelines
1
Protection & Security
1
Women & Child Health
1
Primary Health Care
1
Leishmaniasis
1
Human African Trypanosomiasis
1
Disease Prevention & Control
1
Pharmacy & Technologies
1
Toolboxes
Country specific documents
50
Biontech/Pfizer Comirnaty
23
Communication Material
19
Immunization Guidelines
16
Fair Allocation & Ethical Aspects
15
Access & Strategy
13
COVID-19 Vaccination Information
12
Logistics & Supply
11
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
10
Children/Adolescents Mental Disorders
10
COVID-19 Vaccination
9
Vaccine Hesitancy & Myths
9
Vaxzevria (Astra Zeneca)
9
Booster Doses
8
For General Public & Community
7
Hospital Readiness/Essential Health Services
7
Dashboards & Resource Platforms
7
Global Impact: Socio-economic, health services, TB & HIV
6
mRna Vaccines general
6
Moderna
6
TB/HIV Coinfection
6
General
5
Infection Control General
5
Videos
5
COVAX Initiative
5
Long COVID/ Post-COVID Syndrome
5
Vector-based Vacines General
5
Research & Pipeline
5
Inactivated COVID-19 Vaccines
5
Neurological Disorders
5
Meningitis Prevention & Control
4
Studies
4
General
4
Vaccine Candidates & Research
4
Capacity Building & Resources
4
Alzheimer's Disease & Dementia
4
Substance Use Disorders & Addiction
4
Anxiety Disorders
4
Sustainable Development Goals
3
Cannabis
3
Online Courses & Resources
3
Training, others
3
For Health Worker
3
For Migrants & Refugees
3
Scientific & Research Studies
3
Educational Settings
3
Workplace
3
Physical Distancing
3
SARS-CoV-2 Variants
3
Information Refugees Ukraine
3
COVID-19
3
Education material
3
Statistics & Facts
3
Studies & Reports
3
Clinical Aspects & Diagnostics
3
Drug resistant TB
3
Vision Loss & Blindness
3
Global Health Institutions and Stakeholders
3
Background PTSD in children
2
Treatment & Prevention
2
Country specific
2
Children & Adolescents
2
Anamnesis / Screening
2
Stroke
2
Social Worker
2
Health Personnel
2
COVID-19 Information
2
For Parents & Children
2
For Pregnant Women
2
Faith-based Organizations
2
Appeals and Response Plans
2
Information for the Public
2
Paediatrics
2
Mythbusters/Misinformation
2
Tips & Best Practice Examples
2
Vaccination & Strategy
2
Studies & Reports
2
Essential Medicines
2
Prices and Patents
2
Situation Reports & Updates
2
General Information & Methodology
2
Health Financing Toolbox
2
Women
2
General
2
Research & Access
2
Refugees & Migrants
2
Depression
2
Meningitis & Encephalitis
2
Volunteers
2
Africa
1
Rapid Response
1
Clinical Guidelines
1
Policies & Strategies
1
Assessment & Studies
1
ART Drug Resistance
1
Local Action
1
General Reports
1
Agriculture & Veterinary
1
IEC Materials General
1
IPC
1
Vaccines & Immunization
1
Prevention & Control
1
Vaccination
1
Adults
1
Pediatrics
1
Information for Refugees & Migrants
1
Schizophrenia
1
General Mental Health Guidelines
1
Public Health
1
Orphans & vulnerable children
1
Stigma & Discrimination
1
General Studies & Reports
1
Latin America
1
Discrimination & Stigma
1
Child Health / Pediatrics
1
Attention deficit hyperactivity disorder (ADHD)
1
Mental Health Guidelines
1
Epilepsy
1
International
1
Situation Reports & Updates
1
Prevention & Preparedness
1
Research & Development
1
COVID-19
1
Public Health
1
Poster & Infographics
1
Video & Audio
1
Diagnostics & Laboratory Guidance
1
Surveillance & Contact tracing
1
Dashboards & Maps
1
Human Rights
1
For Older People
1
Resource Platforms others
1
Country-specific Platforms
1
HIV and COVID-19
1
At Home
1
Gambling
1
Non-pharmaceutical interventions (NPIs)
1
Long-term Care Facilities
1
Johnson & Johnson
1
Sputnik V
1
Hygiene
1
Sanitation
1
Extreme Situations
1
Nurses
1
Chile
1
Falsified & Substandard
1
HIV &TB
1
Epilepsy
1
Reports & Studies
1
Zoonoses
1
WASH Water Sanitation & Hygiene
1
MPOX - Monkeypox
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Onchocerciasis
1
General Information
1
Global Overview
1
General
1
War Surgery & Wound Care
1
Policies and guidelines
1
others
1
Clinical Guidelines
1
Bipolar Affective Disorders
1
Protection
1
Human Rights & the Right to Health
1
TB & Prisoners
1
Policy
1
Health Care Systems
1
Assessment
1
Clinical Guidelines
1
Antiretroviral Treatment ART
1
TB
1
Lobby and Advocacy
1
Eastern Europe & Central Asia
1
Laboratory & Diagnostics
1
Neurological disorders, Others
1
Global Health Ethics
1
Communication & Training
1
Preparedness & Prevention
1
Lancet Glob Health 2018, Published Online September 12, 2018 http://dx.doi.org/10.1016/S2214-109X(18)30387-5
Lancet Glob Health 2018 Published Online September 12, 2018 http://dx.doi.org/10.1016/S2214-109X(18)30407-8
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
Lancet Planet Health 2017 Published Online November 6, 2017 http://dx.doi.org/10.1016/S2542-5196(17)30141-9
Cognitive deficits in schizophrenia can massively impact functionality and quality of life, furthering the importance of cognitive training. Despite the development of the field in Europe and in the United States, no programmes have been developed and tested in developing countries. Different cultur...
Documentation des meilleures pratiques et des goulots d’étranglement à la mise en œuvre du programme au Sénégal .
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea...
USAID Senegal and Health in Africa (HIA) initiative of the World Bank Group engaged the Strengthening Health Outcomes through the Private Sector (SHOPS) project to conduct an assessment of the private health sector in Senegal. The assessment’s primary focus is family planning, and its secondary fo...
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic use is increasing steadily (table 1), particularly ...
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs...
DOI:https://doi.org/10.1016/S2213-2600(20)30316-7
The Lancet Respiratory Medicine
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
Manuel d’orientation
Recommandations concernant l’utilisation de méthodes
contraceptives par les femmes exposées à un risque
élevé d’infection par le VIH
Guidance statement
Recommendations on contraceptive methods used by
women at high risk of HIV
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
